Back to Journals » Therapeutics and Clinical Risk Management » Volume 4 » Issue 5

Should patients set the agenda for informed, consent? A prospective survey of desire for information and discussion prior to routine cataract surgery

Authors Tan L, Jenkins H, Roberts-Harry J, Austin M

Published 10 October 2008 Volume 2008:4(5) Pages 1119—1125


Review by Single-blind

Peer reviewer comments 2

Lee Teak Tan1,2, Huw Jenkins1,2, John Roberts-Harry2, Michael Austin1

1Singleton Hospital, Swansea, UK; 2West Wales General Hospital, Carmarthen, UK

Purpose: To ascertain the level of information relating to specific risks desired by patients prior to cataract surgery.

Setting: Dedicated cataract surgery pre-assessment clinics of 2 hospitals in South West Wales, UK.

Methods: Consecutive patients (106) were recruited prospectively. Of these, 6 were formally excluded due to deafness or disorientation. Eligible patients (100) were asked a set of preliminary questions to determine their understanding of the nature of cataract, risk perception, and level of information felt necessary prior to giving consent. Those who desired further information were guided through a standardized questionnaire, which included an audio-visual presentation giving information relating to each potential surgical complication, allowing patients to rate them for relevance to their giving of informed consent.

Results: Of the entire group of 100, 32 did not wish to know “anything at all” about risks and would prefer to leave decision making to their ophthalmologist; 22 were interested only in knowing their overall chance of visual improvement; and 46 welcomed a general discussion of possible complications, of whom 25 went on to enquire about specific complications. Of these 25, 18 wished to be informed of posterior capsular (PC) tearing, 17 of endophthalmitis, 16 each of dropped lens, retinal detachment and corneal clouding, and 15 of bleeding, sympathetic ophthalmia, and PC opacification.

Conclusion: Patients differ in their desire for information prior to cataract surgery, with one significant minority favoring little or no discussion of risk and another wishing detailed consideration of specific risks. A system of consent where patients have a choice as to the level of discussion undertaken may better suit patients’ wishes than a doctor-specified agenda.

Keywords: cataract extraction, informed consent, patient-centered care

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 


Readers of this article also read:

Enhanced bioavailability and anthelmintic efficacy of mebendazole in redispersible microparticles with low-substituted hydroxypropylcellulose

Torre-Iglesias PM, García-Rodriguez JJ, Torrado G, Torrado S, Torrado-Santiago S, Bolás-Fernández F

Drug Design, Development and Therapy 2014, 8:1467-1479

Published Date: 18 September 2014

A rehabilitation program for lung cancer patients during postthoracotomy chemotherapy

Hoffman AJ, Brintnall RA, von Eye A, Jones LW, Alderink G, Patzelt LH, Brown JK

OncoTargets and Therapy 2014, 7:415-423

Published Date: 10 March 2014

Triolein-based polycation lipid nanocarrier for efficient gene delivery: characteristics and mechanism

Zhang ZW, Fang XL, Hao JG, Li YJ, Sha XY

International Journal of Nanomedicine 2011, 6:2235-2244

Published Date: 7 October 2011

Predictability and stability of refraction with increasing optical zone diameter in hyperopic LASIK

Mostafa A El-Helw, Ahmed M Emarah

Clinical Ophthalmology 2010, 4:455-458

Published Date: 11 May 2010

Imitation and communication skills development in children with pervasive developmental disorders

Andrea De Giacomo, Claudia Portoghese, Domenico Martinelli, Isabella Fanizza, et al.

Neuropsychiatric Disease and Treatment 2009, 5:355-362

Published Date: 18 June 2009

Exemestane in early breast cancer: a review

Michael Untch, Christian Jackisch

Therapeutics and Clinical Risk Management 2008, 4:1295-1304

Published Date: 5 December 2008

Pharmacological management of acute bronchiolitis

Melvin Wright, Charles J Mullett, Giovanni Piedimonte

Therapeutics and Clinical Risk Management 2008, 4:895-903

Published Date: 10 October 2008

Treatment strategies in mucous membrane pemphigoid

Ann G Neff, Matthew Turner, Diya F Mutasim

Therapeutics and Clinical Risk Management 2008, 4:617-626

Published Date: 6 June 2008

“One pill, once daily”: what clinicians need to know about Atripla™

Patrick G Clay, Tracey AH Taylor, Alan G Glaros, MaryPeace McRae, Charlott Williams, et al

Therapeutics and Clinical Risk Management 2008, 4:291-302

Published Date: 11 April 2008